Follow us on:

Linkedin Facebook

Inspire Medical Systems, Inc. – Consensus ‘buy’ rating and 3.9% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Inspire Medical Systems, Inc. with ticker code (INSP) have now 10 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 360 and 300 and has a mean target at $314.50. Given that the stocks previous close was at $302.84 this now indicates there is a potential upside of 3.9%. The 50 day moving average now sits at $258.09 and the 200 moving average now moves to $231.57. The total market capitalization for the company now stands at 8.79B. The stock price for the company is currently 301.38 USD

The potential market cap would be $9,130,394,716 based on the market consensus.

USD

The company has a dividend yield of 2.05%. Other points of data to note are a P/E ratio of -, revenue per share of 16.38 and a -7.4% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Broker Ratings

    Inspire Medical Systems, Inc. Share Price Target ‘$239.60’, now 24.3% Upside Potential

    Broker Ratings

    Inspire Medical Systems, Inc. – Consensus ‘buy’ rating and 25.1% Upside Potential

    Broker Ratings

    Inspire Medical Systems, Inc. – Consensus ‘buy’ rating and 24.3% Upside Potential

    Broker Ratings

    Inspire Medical Systems, Inc. Share Price Target ‘$239.60’, now 26.7% Upside Potential

    Broker Ratings

    Inspire Medical Systems, Inc. Share Price Target ‘$239.87’, now 28.8% Upside Potential

    Broker Ratings

    Inspire Medical Systems, Inc. – Consensus ‘buy’ rating and 37.5% Upside Potential

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.